Pulmonary Embolism | Radcliffe Cardiology
custom-link { transition: background 0.1s ease; font-size: inherit; font-weight: 600; line-height: 1.25em; letter-spacing: 0.1em; } .button-filled-white { color: #0F1B36; background: rgba(255,255,255,1); padding: 0.75em 1.5em; border: rgba(255,255,255,0); margin: 0px 20px 10px 0px; } .button-filled-white:hover { background: rgba(255,255,255,0.8); border: rgba(255,255,255,0.8); } @media (max-width: 768px) { /* Apply styles for screens up to 768px wide (e.g., mobile devices) */ a { width: 70%; /* Set width to 70% for mobile layout */ margin: 0 auto 10px; /* Center align and add bottom margin */ } } Please click below to view 4 broadcasts about changing the Status Quo in PE Treatment: Patient Selection Patient Pathway Immediate Impact Clinical Data Venous thromboembolism is a serious disease. Both deep vein thrombosis and pulmonary embolism frequently result in devastating impacts for patients in both the short and the long term. Pulmonary Embolism affects about 1000 out of every 1 mi